CMS Works Toward Additional Compendia For Off-Label Cancer Drug Coverage

The Centers for Medicare & Medicaid Services aims to solicit public comments within the next several weeks on proposed criteria and processes for identifying compendia to be used by Medicare Part B contractors in making local coverage determinations for off-label cancer drugs and biologicals